Dr Cumeras works with two organisations using specific IMS instruments. They...
Dr Cumeras works with two organisations using specific IMS instruments. They are, (left image) - GC-IMS: FlavourSpec from GAS. In collaboration with Prof. Santiago Marco from the Signal and information processing for sensing systems research group at the Institute for Bioengineering of Catalonia (IBEC). (right image), LC-IMS-MS: 6560 from Agilent. In collaboration with biotechnology company, oloBion, based at Parc Científic de Barcelona.

Exploring the potential of IMS

Ion mobility spectrometry: Rapid results from breath analysis

Ion-mobility spectrometry (IMS) offers opportunities for rapid diagnosis and clinical decision-making due to breath analysis. As a rapid separation tool, it has clinical value in the identification and analysis of proteins, peptides, lipids, and glycans. The tool is already used as an exhaled drug monitor for anaesthetised patients.

Report: Mark Nicholls

portrait of Raquel Cumeras
Dr Raquel Cumeras

It is flexible, portable and has use for point-of-care testing, or remotely where a patient does not need to be in a clinic, explained post-doctoral researcher Dr Raquel Cumeras.

Ion-mobility spectrometry (IMS) is an analytical technique used to separate vaporised and ionised molecules based on their mobility under the influence of an electric field and their interactions with a carrier buffer gas. As a rapid separation tool, it can be coupled with several sampling/ionisation methods, other separation techniques such as gas chromatography (GC-IMS), and various detectors, including mass spectrometry.

Cumeras, who is a Marie Curie postdoctoral fellow at the Institute of Health Research Pere Virgili (IIPSV), and affiliated to the University Rovira i Virgili (URV) at the Department of Electrical Electronic Engineering and Automation in Tarragona, Spain, explained that the mobility is related to the chemical shape. ‘What makes it even more attractive is that it works in the millisecond range,’ she added, ’making IMS perfect for analytical chemistry mass spectrometry instrumentation, where chromatography is in the second range, and mass detectors are in the microsecond range. So, IMS can be placed in between second > millisecond > microsecond.’

In addition, Cumeras said a whole new branch of applications has emerged with liquid injection now possible (liquid chromatography - LC) with the new mass spectrometry instrumentation. These can include differentiation of isomeric chemical compounds, such as breath or volatiles for GC-IMS and proteins, peptides, lipids, and glycans for the LC-IMS-MS.

Ion mobility spectrometry should be understood as a complementary tool for specific molecules

Raquel Cumeras

Over the past two decades, IMS became established for the detection of illicit drugs or chemical warfare agents, but it is becoming attractive for use in clinical laboratories due to the high speed of analysis. The main instrumentation developments have been in research labs, though this is increasingly being performed by specialised analytical chemistry start-ups or vendors. However, data processing and analysis, as well as database generation and curation, remain major fields of research. ‘Ion mobility spectrometry should be understood as a complementary tool for specific molecules,’  Cumeras explained. ‘It will help the clinical laboratory testing units to improve the analysis speed, the specificity, and maybe the cost.’

New applications

IMS has opportunities in healthcare because different IMS instrumentations exist, with each using different ways to generate the electric field, including drift tube IMS (DTIMS), field asymmetric IMS (FAIMS), traveling wave IMS (TWIMS), trapped IMS (TIMS), and differential mobility analysers (DMA). ‘FAIMS have been shown as a great option for portable in-field instrumentation (GC-IMS) while the others are mainly hyphenated to a mass spectrometer,’ she said. ‘These will lead to point-of-care application for FAIMS, like breath analysis or infection determination, while the rest are being applied to other diseases that do not need the patient to be in the office.’ 

A new application of IMS for pathology is also under development in several research labs. ‘Ion mobility has an exciting future, as disease specific applications are developed and most importantly, validated, she confirmed. In some areas, patients are already feeling the benefits of IMS. One available instrument, based on IMS, is the Edmon, an exhaled drug monitor of propofol, for patients receiving anaesthesia or sedation.


Profile:

Dr Raquel Cumeras is a Marie Curie postdoctoral fellow at the Institute of Health Research Pere Virgili (IIPSV), and affiliated to the University Rovira I Virgili (URV) at the Department of Electrical Electronic Engineering and Automation in Tarragona, Spain. Her research interests are in data learning for metabolomics, understood as the intersection of metabolomics, signal processing, meta-analysis, and machine learning for clinical applications.

09.12.2021

Read all latest stories

Related articles

Photo

POCT

Evolutionary POCT

A growing number of clinical tests are being delivered in community hospitals with more patients receiving quicker, accurate diagnoses closer to home, without stays in acute hospital beds. Professor…

Photo

Antimicrobial stewardship

A diagnostic marker reduces antibiotics use

Since 2009, as part of diagnostic and antimicrobial stewardship strategies, Hampshire Hospitals National Health Service (NHS) Trust has used serum procalcitonin (PCT) – an innovative and highly…

Photo

Point-of-care testing

Emerging technologies in POCT

Considerable advances in point-of-care testing (POCT) devices are emerging from lab-on-a-chip platforms, innovations in smartphone-based technology and wearable technology. Cloud-based deep learning…

Related products

Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Clinical Chemistry

Alsachim - Dosimmune immunosupressant Alsachim – kit (CE-IVD or RUO)

Alsachim, a Shimadzu Group Company
Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Clinical Chemistry

Alsachim – Dosimyco immunosupressant reagent kit (RUO)

Alsachim, a Shimadzu Group Company
Beckman Coulter – Access 2 Immunoassay System

Immunoassays

Beckman Coulter – Access 2 Immunoassay System

Beckman Coulter Diagnostics
Beckman Coulter – AU5800 Series

Clinical Chemistry

Beckman Coulter – AU5800 Series

Beckman Coulter Diagnostics
Beckman Coulter – DxC 700 AU

Clincal Chemistry

Beckman Coulter – DxC 700 AU

Beckman Coulter Diagnostics
Beckman Coulter – HbA1c Advanced

Clinical Chemistry

Beckman Coulter – HbA1c Advanced

Beckman Coulter Diagnostics
Subscribe to Newsletter